>From: "Vale, Luke" <[log in to unmask]>
>
>Dear Colleagues
>
>I am trying to identify reviews of economic evaluation, either
>published or unpublished.  Can any of you who receive this message please
>let me know of the bibliographic details of any reviews that you may be
>aware of.
>Copied below are the list of papers that I've already identified
>
>many thanks for any help
>
>Luke Vale
>Research Fellow
>HERU
>University of Aberdeen
>
>
>Adams 1992
>Adams, M.E., McCall, N.T., Gray, D.T., Orza, M.J., Chalmers, T.C.
>Economic
>analysis in randomised controlled trials. Medical Care 1992; 30:231-38.
>
>Barber 1998
>Barber JA, Thompson SG. Analysis and interpretation of cost data in
>randomised controlled trials: review of published studies. BMJ 1998;
>317:1195-1200.
>
>Brazier 1999
>Brazier J, Deverill M, Green C, Harper R, Booth A. A review of the use =
>of
>health status measures in economic evaluation. Health Technology =
>Assessment
>1999; 3(9).
>
>(Briggs AH, Gray AM. Handling uncertainty when performing economic
>evaluations of healthcare interventions. Health Technology Assessment =
>1999;
>3(2).)=20
>
>Demicheli 1997
>Demicheli V, Jefferson T. An exploratory review of the economics of
>recombinant vaccines against Hepatitis B (HB). Ronchi E, Editor. The
>Economic aspect of Biotechnologies related to human healt: =
>Biotechnology and
>medical innovation: Socio-economic assessment of the technology, the
>potential and the products. France: OECD, 1997.
>
>Diener 1998
>Diener A, O'Brien B, Gafni A.  Health care contingent valuation =
>studies: a
>review and classification of the literature.  Health Econ 1998; 7(4):
>313-26.
>
>Evers 1997
>Evers SM, Van Wijk AS, Ament AJ. Economic evaluation of mental health =
>care
>interventions. A review. Health Econ 1997; 6(2):161-77.
>
>Hill 2000
>Hill SH, Mitchell A, Henry D.  Problems with the interpretation of
>pharmacoeconomic analyses.  A review of submissions to the Australian
>Pharmaceutical Benefits Scheme. JAMA 2000; 283(16): 2116-21.
>
>Gerard 1992
>Gerard, K. Cost-utility in practice: a policy maker's guide to the =
>state of
>the art. Health Policy 1992; 21: 249-79.
>
>Gerard 2000
>Gerard K et al. A tool to improve quality of reporting published =
>economic
>analysis. Intl J Techn Assess Health Care 2000; 16:100-110.
>
>Jacobs 1998
>Jacobs P, Fassbender K. The measurement of indirect costs in the health
>economics evaluation literature. Intl J Techn Assess Health Care 1998;
>14:799-808.
>
>Jefferson 1994
>Jefferson T, Demicheli V. Is vaccination against hepatitis B efficient? =
>A
>review of world literature. Health Econ 1994; 3:25-37.
>
>Jefferson 1996
>Jefferson T, Demicheli V. Economic evaluation of influenza vaccination =
>and
>economic modelling - can results be pooled? Pharmacoeconomics 1996; =
>9(Suppl
>3):67-72.
>
>Hutton 1999
>Hutton J, Iglesias C, Jefferson TO. Assessing the potential
>cost-effectiveness of pneumococcal vaccines: methodological issues and
>current evidence. Drugs and Aging 1999 15 Suppl 1:31-36.
>
>Neumann 2000
>Neumann PJ, Stone PW, Chapman RH, Sandberg EA,  Bell CM. The quality of
>reporting in published Cost-Utility Analyses, 1976-1997. Ann Int Med
>2000;132:964-72.
>
>Petrou 2000
>Petrou S, Henderson J, Roberts T, Martin M-A. Recent economic =
>evaluations of
>antenatal screening: a systematic review and critique. J Med Screening =
>2000;
>&(2): 59-73. (previously: Roberts T, Henderson J, Petrou S, Martin M. =
>The
>quality of economic evidence available to decision makers.  2nd
>international conference on priority setting).=20
>
>Schrappe 1998
>Schrappe M, Lauterbach K. Systematic review on the cost-effectiveness =
>of
>public health interventions for HIV prevention in industrialised =
>countries.
>AIDS 1998; 12(Supplement A):S231-S239.
>
>Sp=E4th 1999
>Sp=E4th H-M, Carr=E8re M-O, Fevers BPT. Analysis of the eligibility of =
>published
>economic evaluations for transfer to a given health care system -
>methodological approach and application to the French Health Care =
>System .
>Health Policy 1999; 161-177.
>
>Udvarhelyi 1992
>Udvarhelyi, S, Colditz, GA, Rai A, Epstein AM. Cost-effectiveness and=20
>Cost-benefit analyses in the medical literature. Are methods being used =
>
>correctly? Annals of Internal Medicine, 1992: 116:238-44.
>
>Brown 1998
>Brown ML, Fintor L. Cost-effectiveness of breast cancer screening:
>preliminary results of a systematic review of the literature. Res Pol =
>1998;
>3:108-12.
>
>Byford 1998
>Byford S, Palmer S. Common errors and controversies in pharmacoeconomic
>analyses. Pharmacoeconomics 1998; 13:659-666.
>
>Dere 1998
>Dere W, Avouac B, Boers M et al. Recommendations for the Health =
>Economics
>Analysis to be performed with a drug to be registered in prevention or
>treatment of osteoporosis. Calcif Tissue Int 1998; 63:93-7.
>
>Evans 1997
>Evans C.  The use of consensus methods and expert panels in =
>pharmacoeconomic
>studies: practical applications and methodological shortcomings.
>Pharmacoeconomics 1997; 12(2 Pt 1): 121-9.
>
>Gerard 1999
>Gerard K, Smoker I, Seymour J. Raising the quality of cost-utility =
>analyses:
>lessons learnt and still to learn. Health Policy 1999; 46:219-238.
>
>Goossens 1997
>Goossens ME, Evers SM. Economic evaluation of back pain interventions.
>Journal of Occupational Rehabilitation 1997; 7(1):15-32.
>
>Jefferson 1998
>Jefferson T, Demicheli V. Methodological quality of economic modelling
>studies - A case study with hepatitis B vaccines. Pharmocoeconomics =
>1998;
>14(3):251-7.
>
>Jefferson 1999
>Jefferson T, Demicheli V, Rivetti D, Deeks J. Cochrane reviews and
>systematic reviews of economic evaluations. Pharmacoeconomics 1999; 16
>(Supplement 1):85-9.
>
>Jefferson 1996b
>Jefferson T, Mugford M, Gray A, Demicheli V. An exercise on the =
>feasibility
>of carrying out secondary economic analyses. Health Econ 1996; =
>5:155-65.
>
>MacLeod 1998
>Macleod A, Donaldon C, Khan I et al. Effectiveness and efficiency of =
>methods
>of dialysis therapy for end stage renal disease: systematic reviews.  =
>Health
>Technol Assessment  1998; 2(5).
>
>Morris 1997
>Morris S, McGuire A, Caro J, Pettitt D. Strategies for the management =
>of
>hypercholesterol-aemia: a systematic review of the cost-effectiveness
>literature. Journal of Health Service Research Policy 1997; =
>2(4):231-50.
>
>Mugford 1993
>Mugford M, Chalmers I. A step towards using the results of RCTs in =
>resource
>allocation decisions.  Proceedings of the European Conference: 'From
>economic analysis to health policies' . University of Paris, Dauphine, =
>1993:
>171-5.
>
>Mugford 1989
>Mugford M, Kingston J, Chalmers I. Reducing the incidence of infection =
>after
>caesarean section: implications of prophylaxis with antibiotics for =
>hospital
>resources. British Medical Journal 1989; 299(6706):1003-6.
>
>Mugford 1991
>Mugford M, Piercy J, Chalmers I. Cost implications of different =
>approaches
>to the prevention of respiratory distress syndrome. Arch Dis Child =
>1991;
>66:757-64.
>
>Mugford 1994
>Mugford M. Steroids for women expected to deliver prematurely.  =
>Estimates of
>impact of wider use. Oxford Regional Health Authority, Oxford, 1994.
>
>Mugford 1995
>Mugford M. The cost of neonatal care: reviewing the evidence. Soz
>Praventivmed 1995; 40(6):361-8.
>
>Neymark 1998
>Neymark N. Review on evidence-based cancer medicine - Critical reviews =
>of
>economic analyses in order to make health care decisions for cancer. =
>Ann
>Oncol 1998; 9:1167-72.
>
>Nord 1999
>Nord E. Cost value analysis of health care: making sense out of QALYs.
>Cambridge University Press 1999.
>
>Pang 1999
>Pang F, Drummond M, Song F.  The use of meta-analysis in economic
>evaluation.  Centre for Health Economics, Discussion paper 173.  =
>University
>of York, 1999.
>
>Rigby 1996
>Rigby K, Silagy C. Can resource use be extracted from randomised =
>controlled
>trials to calculate costs? Int J Technol Assess Health Care 1996;
>12(4):714-20.
>
>Sanchez 1999
>Sanchez C, Munoz D, Monti M, DiCarlo N, Ordozoity N. Cost evaluation of
>Clozapine in patients with chronic schizophrenia. 1999.=20
>
>Trakas 1997
>Trakas K, Addis A, Kruk D et al. Quality assessment of =
>pharmacoeconomics
>abstracts of original research articles in selected journals. Ann
>Pharmacother 1997; 31:423-8.
>
>
>Gift=20
>Gift T, Kassler W, Wang G. Assessing the quality of economic studies of
>health care--searching for an ideal instrument. Conference Proceedings =
>-
>Centers for Disease Control and Prevention, Atlanta, GA .